| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macaca fascicularis | 40 | 2015 | 542 | 2.810 |
Why?
|
| Soybean Proteins | 13 | 2015 | 101 | 1.830 |
Why?
|
| Isoflavones | 13 | 2015 | 103 | 1.570 |
Why?
|
| Atherosclerosis | 8 | 2015 | 820 | 1.380 |
Why?
|
| Ovary | 8 | 2014 | 66 | 1.200 |
Why?
|
| Animals | 67 | 2017 | 8199 | 1.150 |
Why?
|
| Ovarian Follicle | 6 | 2014 | 36 | 1.110 |
Why?
|
| Premenopause | 6 | 2012 | 53 | 1.060 |
Why?
|
| Disease Models, Animal | 10 | 2015 | 1083 | 1.000 |
Why?
|
| Diet | 10 | 2015 | 383 | 0.970 |
Why?
|
| Anti-Mullerian Hormone | 5 | 2014 | 20 | 0.870 |
Why?
|
| Lipids | 7 | 2013 | 253 | 0.860 |
Why?
|
| Ovarian Diseases | 3 | 2010 | 9 | 0.810 |
Why?
|
| Estrogens | 6 | 2008 | 194 | 0.760 |
Why?
|
| Female | 58 | 2017 | 19945 | 0.710 |
Why?
|
| Ovariectomy | 11 | 2015 | 202 | 0.680 |
Why?
|
| Lactalbumin | 4 | 2014 | 15 | 0.670 |
Why?
|
| Caseins | 4 | 2014 | 21 | 0.670 |
Why?
|
| Body Weight | 10 | 2013 | 323 | 0.670 |
Why?
|
| Soybeans | 3 | 2014 | 42 | 0.610 |
Why?
|
| Adrenal Cortex | 2 | 2011 | 5 | 0.570 |
Why?
|
| Postmenopause | 5 | 2015 | 424 | 0.550 |
Why?
|
| Social Dominance | 6 | 2012 | 24 | 0.520 |
Why?
|
| Pregnancy | 3 | 2015 | 961 | 0.520 |
Why?
|
| Models, Animal | 6 | 2013 | 188 | 0.510 |
Why?
|
| Reproduction | 3 | 2014 | 17 | 0.510 |
Why?
|
| Estradiol | 8 | 2012 | 139 | 0.510 |
Why?
|
| Coronary Disease | 2 | 2008 | 226 | 0.490 |
Why?
|
| Coronary Vessels | 6 | 2012 | 174 | 0.470 |
Why?
|
| Iliac Artery | 3 | 2015 | 50 | 0.470 |
Why?
|
| Hematologic Tests | 1 | 2015 | 12 | 0.460 |
Why?
|
| Dietary Proteins | 4 | 2014 | 63 | 0.450 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2013 | 907 | 0.430 |
Why?
|
| Dietary Supplements | 2 | 2015 | 188 | 0.430 |
Why?
|
| Primates | 3 | 2017 | 128 | 0.420 |
Why?
|
| Diet, Atherogenic | 7 | 2015 | 74 | 0.390 |
Why?
|
| Menopause | 4 | 2014 | 109 | 0.390 |
Why?
|
| Genetic Variation | 6 | 2015 | 248 | 0.360 |
Why?
|
| Aging | 8 | 2014 | 942 | 0.360 |
Why?
|
| Pyrrolidines | 1 | 2011 | 16 | 0.350 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2011 | 33 | 0.350 |
Why?
|
| Coronary Artery Disease | 6 | 2015 | 427 | 0.350 |
Why?
|
| Anatomy, Cross-Sectional | 2 | 2010 | 19 | 0.350 |
Why?
|
| Sexual Development | 1 | 2010 | 4 | 0.330 |
Why?
|
| Macaca mulatta | 6 | 2009 | 340 | 0.330 |
Why?
|
| Arteriosclerosis | 3 | 2004 | 147 | 0.310 |
Why?
|
| Papio | 2 | 2015 | 78 | 0.310 |
Why?
|
| Osteoporosis | 2 | 2008 | 51 | 0.310 |
Why?
|
| Pelvis | 1 | 2010 | 67 | 0.310 |
Why?
|
| Homovanillic Acid | 4 | 2015 | 15 | 0.310 |
Why?
|
| Hierarchy, Social | 1 | 2009 | 26 | 0.300 |
Why?
|
| Menstrual Cycle | 6 | 2012 | 32 | 0.300 |
Why?
|
| Perimenopause | 1 | 2009 | 14 | 0.300 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2009 | 90 | 0.280 |
Why?
|
| Animal Feed | 5 | 2015 | 23 | 0.270 |
Why?
|
| Primate Diseases | 1 | 2008 | 4 | 0.270 |
Why?
|
| Stress, Physiological | 1 | 2008 | 56 | 0.260 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2006 | 1437 | 0.260 |
Why?
|
| Methoxyhydroxyphenylglycol | 2 | 2004 | 2 | 0.260 |
Why?
|
| Hydroxyindoleacetic Acid | 2 | 2004 | 19 | 0.260 |
Why?
|
| Male | 20 | 2017 | 19441 | 0.250 |
Why?
|
| Phytoestrogens | 1 | 2006 | 25 | 0.240 |
Why?
|
| Random Allocation | 5 | 2015 | 247 | 0.230 |
Why?
|
| Monkey Diseases | 1 | 2006 | 27 | 0.230 |
Why?
|
| Coronary Circulation | 1 | 2005 | 41 | 0.230 |
Why?
|
| Organ Size | 4 | 2011 | 221 | 0.230 |
Why?
|
| Prediabetic State | 1 | 2006 | 76 | 0.220 |
Why?
|
| Vinyl Compounds | 3 | 2010 | 12 | 0.220 |
Why?
|
| Progestins | 1 | 2004 | 27 | 0.220 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 3 | 2009 | 22 | 0.210 |
Why?
|
| Genital Neoplasms, Female | 1 | 2004 | 29 | 0.200 |
Why?
|
| Behavior, Animal | 5 | 2015 | 299 | 0.190 |
Why?
|
| Vitamin D | 2 | 2015 | 186 | 0.190 |
Why?
|
| Calcifediol | 2 | 2012 | 10 | 0.190 |
Why?
|
| Receptors, Calcitriol | 2 | 2012 | 13 | 0.190 |
Why?
|
| Biogenic Monoamines | 1 | 2002 | 10 | 0.180 |
Why?
|
| Women's Health | 1 | 2004 | 230 | 0.180 |
Why?
|
| Reference Values | 3 | 2015 | 238 | 0.180 |
Why?
|
| Central Nervous System | 1 | 2002 | 47 | 0.180 |
Why?
|
| Linkage Disequilibrium | 2 | 2015 | 181 | 0.180 |
Why?
|
| Genotype | 4 | 2015 | 702 | 0.170 |
Why?
|
| Cyclohexenes | 3 | 2010 | 17 | 0.170 |
Why?
|
| Insulin Resistance | 4 | 2012 | 458 | 0.170 |
Why?
|
| C-Reactive Protein | 2 | 2012 | 227 | 0.160 |
Why?
|
| Regression Analysis | 2 | 2011 | 273 | 0.160 |
Why?
|
| Social Behavior | 5 | 2015 | 69 | 0.150 |
Why?
|
| Sex Factors | 4 | 2013 | 655 | 0.150 |
Why?
|
| Humans | 16 | 2017 | 32282 | 0.150 |
Why?
|
| Hippocampus | 2 | 2011 | 216 | 0.150 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 2 | 2012 | 112 | 0.150 |
Why?
|
| Sex Characteristics | 2 | 2015 | 173 | 0.150 |
Why?
|
| Radiation Dosage | 2 | 2010 | 91 | 0.140 |
Why?
|
| Phylogeny | 3 | 2015 | 67 | 0.140 |
Why?
|
| Androgens | 2 | 2011 | 30 | 0.140 |
Why?
|
| Temporal Lobe | 2 | 2015 | 34 | 0.140 |
Why?
|
| Animal Nutritional Physiological Phenomena | 3 | 2013 | 12 | 0.140 |
Why?
|
| Cardiovascular Diseases | 3 | 2013 | 1158 | 0.140 |
Why?
|
| Positron-Emission Tomography | 2 | 2016 | 171 | 0.140 |
Why?
|
| Social Environment | 3 | 2009 | 74 | 0.140 |
Why?
|
| Hydrocortisone | 4 | 2011 | 61 | 0.130 |
Why?
|
| Inheritance Patterns | 1 | 2017 | 11 | 0.130 |
Why?
|
| Lewy Body Disease | 1 | 2017 | 6 | 0.130 |
Why?
|
| Nerve Degeneration | 1 | 2017 | 16 | 0.130 |
Why?
|
| Ethylamines | 1 | 2016 | 3 | 0.130 |
Why?
|
| Neostriatum | 1 | 2017 | 28 | 0.130 |
Why?
|
| Receptor, Serotonin, 5-HT2C | 1 | 2016 | 7 | 0.130 |
Why?
|
| Receptor, Serotonin, 5-HT2A | 1 | 2016 | 8 | 0.130 |
Why?
|
| Apolipoprotein E4 | 1 | 2017 | 56 | 0.130 |
Why?
|
| Fluorine Radioisotopes | 1 | 2016 | 22 | 0.130 |
Why?
|
| Pedigree | 2 | 2015 | 136 | 0.120 |
Why?
|
| Stress, Psychological | 3 | 2009 | 217 | 0.120 |
Why?
|
| Synapses | 1 | 2017 | 87 | 0.120 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2015 | 36 | 0.120 |
Why?
|
| Docosahexaenoic Acids | 1 | 2015 | 24 | 0.120 |
Why?
|
| Age Factors | 4 | 2014 | 1179 | 0.120 |
Why?
|
| Genome | 1 | 2015 | 38 | 0.120 |
Why?
|
| Brain | 4 | 2017 | 965 | 0.110 |
Why?
|
| Postpartum Period | 1 | 2015 | 36 | 0.110 |
Why?
|
| Menopause, Premature | 1 | 2015 | 11 | 0.110 |
Why?
|
| Personality | 1 | 2015 | 13 | 0.110 |
Why?
|
| Mammary Glands, Animal | 2 | 2006 | 69 | 0.110 |
Why?
|
| Genomics | 1 | 2015 | 89 | 0.110 |
Why?
|
| Asian Continental Ancestry Group | 1 | 2015 | 101 | 0.110 |
Why?
|
| Thyroid Hormones | 1 | 2014 | 7 | 0.110 |
Why?
|
| Neutrophils | 1 | 2015 | 120 | 0.110 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2015 | 1050 | 0.110 |
Why?
|
| Disease Progression | 2 | 2015 | 591 | 0.110 |
Why?
|
| Cocaine | 2 | 2012 | 354 | 0.100 |
Why?
|
| Estrogens, Conjugated (USP) | 2 | 2004 | 157 | 0.100 |
Why?
|
| Cercopithecinae | 1 | 2013 | 3 | 0.100 |
Why?
|
| Simian immunodeficiency virus | 1 | 2013 | 2 | 0.100 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 1 | 2013 | 2 | 0.100 |
Why?
|
| Systems Biology | 1 | 2013 | 10 | 0.100 |
Why?
|
| Polymorphism, Genetic | 3 | 2009 | 179 | 0.100 |
Why?
|
| Liver | 1 | 2015 | 492 | 0.100 |
Why?
|
| Phenotype | 3 | 2015 | 622 | 0.090 |
Why?
|
| Chemokine CCL2 | 2 | 2010 | 48 | 0.090 |
Why?
|
| Oxygen Isotopes | 1 | 2012 | 9 | 0.090 |
Why?
|
| Body Water | 1 | 2012 | 10 | 0.090 |
Why?
|
| Deuterium | 1 | 2012 | 11 | 0.090 |
Why?
|
| Glucose Tolerance Test | 2 | 2009 | 126 | 0.090 |
Why?
|
| Lipid Metabolism | 1 | 2013 | 108 | 0.090 |
Why?
|
| Osteoarthritis | 1 | 2013 | 73 | 0.090 |
Why?
|
| Receptors, Dopamine | 1 | 2012 | 26 | 0.090 |
Why?
|
| Putamen | 1 | 2012 | 28 | 0.090 |
Why?
|
| Hair | 1 | 2012 | 27 | 0.090 |
Why?
|
| Caudate Nucleus | 1 | 2012 | 29 | 0.090 |
Why?
|
| Haplorhini | 2 | 2012 | 75 | 0.090 |
Why?
|
| Cholesterol, HDL | 1 | 2012 | 181 | 0.090 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2012 | 26 | 0.090 |
Why?
|
| Toxicity Tests, Chronic | 1 | 2011 | 4 | 0.090 |
Why?
|
| Gonadotropins | 1 | 2011 | 5 | 0.090 |
Why?
|
| Stimulation, Chemical | 1 | 2011 | 16 | 0.090 |
Why?
|
| Pituitary Gland | 1 | 2011 | 10 | 0.090 |
Why?
|
| Apoptosis | 3 | 2009 | 375 | 0.090 |
Why?
|
| Species Specificity | 3 | 2009 | 98 | 0.090 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 128 | 0.090 |
Why?
|
| Analysis of Variance | 3 | 2012 | 471 | 0.090 |
Why?
|
| Progesterone | 3 | 2014 | 78 | 0.080 |
Why?
|
| Risk Factors | 4 | 2013 | 3934 | 0.080 |
Why?
|
| Estrogen Receptor alpha | 2 | 2008 | 50 | 0.080 |
Why?
|
| Muscle, Smooth | 2 | 2008 | 152 | 0.080 |
Why?
|
| Motor Activity | 1 | 2013 | 332 | 0.080 |
Why?
|
| Androstenedione | 1 | 2010 | 7 | 0.080 |
Why?
|
| Shoulder Joint | 1 | 2013 | 139 | 0.080 |
Why?
|
| Insulin | 2 | 2009 | 359 | 0.080 |
Why?
|
| Peptide Fragments | 1 | 2013 | 415 | 0.080 |
Why?
|
| Testosterone | 1 | 2010 | 48 | 0.080 |
Why?
|
| Antioxidants | 1 | 2011 | 122 | 0.080 |
Why?
|
| Single-Blind Method | 1 | 2010 | 192 | 0.080 |
Why?
|
| Endometrium | 1 | 2010 | 44 | 0.080 |
Why?
|
| RNA, Messenger | 2 | 2008 | 499 | 0.080 |
Why?
|
| Alzheimer Disease | 1 | 2013 | 280 | 0.080 |
Why?
|
| Fructosamine | 1 | 2009 | 12 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2016 | 717 | 0.080 |
Why?
|
| Tamoxifen | 1 | 2010 | 59 | 0.080 |
Why?
|
| Energy Metabolism | 1 | 2011 | 153 | 0.080 |
Why?
|
| Genome, Viral | 1 | 2009 | 12 | 0.080 |
Why?
|
| Dominance-Subordination | 1 | 2009 | 17 | 0.080 |
Why?
|
| Contrast Media | 1 | 2010 | 136 | 0.080 |
Why?
|
| Alphapapillomavirus | 1 | 2009 | 12 | 0.080 |
Why?
|
| Luteinizing Hormone | 1 | 2009 | 16 | 0.080 |
Why?
|
| Interleukin-6 | 1 | 2010 | 224 | 0.070 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2008 | 7 | 0.070 |
Why?
|
| Receptors, Progesterone | 2 | 2006 | 50 | 0.070 |
Why?
|
| Sexual Behavior, Animal | 1 | 2008 | 11 | 0.070 |
Why?
|
| Carcinogens | 1 | 2009 | 36 | 0.070 |
Why?
|
| Estrogen Receptor beta | 2 | 2005 | 14 | 0.070 |
Why?
|
| Menstruation Disturbances | 1 | 2008 | 5 | 0.070 |
Why?
|
| Papillomavirus Infections | 1 | 2009 | 70 | 0.070 |
Why?
|
| Erectile Dysfunction | 1 | 2008 | 69 | 0.070 |
Why?
|
| Vasodilator Agents | 2 | 2005 | 62 | 0.070 |
Why?
|
| Adiponectin | 1 | 2008 | 94 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2010 | 757 | 0.070 |
Why?
|
| Hormones | 1 | 2007 | 24 | 0.070 |
Why?
|
| 3' Untranslated Regions | 1 | 2007 | 25 | 0.070 |
Why?
|
| T-Lymphocytes | 1 | 2008 | 140 | 0.070 |
Why?
|
| Radiographic Image Enhancement | 1 | 2007 | 30 | 0.070 |
Why?
|
| Genetics, Behavioral | 1 | 2007 | 3 | 0.070 |
Why?
|
| Biopsy | 1 | 2008 | 252 | 0.070 |
Why?
|
| Muscle Contraction | 1 | 2008 | 175 | 0.070 |
Why?
|
| Time Factors | 5 | 2014 | 2205 | 0.070 |
Why?
|
| Gene Expression | 2 | 2010 | 346 | 0.070 |
Why?
|
| Radiometry | 1 | 2007 | 52 | 0.060 |
Why?
|
| Urethra | 1 | 2008 | 125 | 0.060 |
Why?
|
| Administration, Oral | 2 | 2006 | 200 | 0.060 |
Why?
|
| Contraceptives, Oral | 2 | 2004 | 26 | 0.060 |
Why?
|
| Cyclohexanes | 1 | 2006 | 6 | 0.060 |
Why?
|
| Laboratory Animal Science | 1 | 2006 | 2 | 0.060 |
Why?
|
| Soy Foods | 1 | 2006 | 8 | 0.060 |
Why?
|
| Genistein | 1 | 2006 | 17 | 0.060 |
Why?
|
| Gonadal Steroid Hormones | 2 | 2006 | 40 | 0.060 |
Why?
|
| Environmental Pollutants | 1 | 2006 | 13 | 0.060 |
Why?
|
| Bone Density | 1 | 2007 | 169 | 0.060 |
Why?
|
| Cercopithecidae | 1 | 2006 | 11 | 0.060 |
Why?
|
| Diet, Protein-Restricted | 1 | 2005 | 3 | 0.060 |
Why?
|
| Nitroglycerin | 1 | 2005 | 10 | 0.060 |
Why?
|
| Disease Susceptibility | 1 | 2006 | 61 | 0.060 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 155 | 0.050 |
Why?
|
| United States | 1 | 2013 | 4072 | 0.050 |
Why?
|
| Quantitative Trait Loci | 2 | 2015 | 140 | 0.050 |
Why?
|
| Hypoglycemic Agents | 1 | 2006 | 186 | 0.050 |
Why?
|
| Maternal Deprivation | 1 | 2004 | 3 | 0.050 |
Why?
|
| Likelihood Functions | 1 | 2004 | 50 | 0.050 |
Why?
|
| Aggression | 1 | 2004 | 27 | 0.050 |
Why?
|
| Amenorrhea | 1 | 2004 | 4 | 0.050 |
Why?
|
| Impulsive Behavior | 1 | 2003 | 8 | 0.050 |
Why?
|
| Animals, Newborn | 1 | 2004 | 136 | 0.050 |
Why?
|
| Serotonin | 1 | 2003 | 44 | 0.050 |
Why?
|
| Base Sequence | 3 | 2009 | 252 | 0.050 |
Why?
|
| Molecular Sequence Data | 3 | 2009 | 359 | 0.050 |
Why?
|
| Physical Conditioning, Animal | 1 | 2003 | 35 | 0.050 |
Why?
|
| Evolution, Molecular | 2 | 2015 | 41 | 0.050 |
Why?
|
| Sexual Maturation | 2 | 2015 | 28 | 0.050 |
Why?
|
| Retrospective Studies | 1 | 2010 | 3626 | 0.050 |
Why?
|
| Steroids | 1 | 2002 | 35 | 0.040 |
Why?
|
| Life Style | 1 | 2004 | 393 | 0.040 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2002 | 80 | 0.040 |
Why?
|
| Muscle, Skeletal | 3 | 2012 | 520 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2004 | 863 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 2004 | 390 | 0.040 |
Why?
|
| Adult | 2 | 2012 | 9259 | 0.040 |
Why?
|
| Exercise | 1 | 2004 | 603 | 0.040 |
Why?
|
| Blood Glucose | 2 | 2012 | 484 | 0.030 |
Why?
|
| Stroke | 1 | 2004 | 691 | 0.030 |
Why?
|
| Injections, Intramuscular | 2 | 2009 | 53 | 0.030 |
Why?
|
| Homozygote | 1 | 2017 | 52 | 0.030 |
Why?
|
| Autopsy | 1 | 2017 | 37 | 0.030 |
Why?
|
| Radioimmunoassay | 2 | 2009 | 25 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2016 | 58 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2016 | 87 | 0.030 |
Why?
|
| Ligands | 1 | 2016 | 90 | 0.030 |
Why?
|
| Alleles | 1 | 2017 | 250 | 0.030 |
Why?
|
| Self Administration | 2 | 2012 | 382 | 0.030 |
Why?
|
| Phenylephrine | 2 | 2008 | 34 | 0.030 |
Why?
|
| Arachidonic Acid | 1 | 2015 | 40 | 0.030 |
Why?
|
| Chromosome Painting | 1 | 2015 | 2 | 0.030 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 2007 | 23 | 0.030 |
Why?
|
| Gene Rearrangement | 1 | 2015 | 12 | 0.030 |
Why?
|
| Major Histocompatibility Complex | 1 | 2015 | 17 | 0.030 |
Why?
|
| Sequence Analysis | 1 | 2015 | 6 | 0.030 |
Why?
|
| Microsatellite Repeats | 1 | 2015 | 22 | 0.030 |
Why?
|
| Computational Biology | 1 | 2015 | 99 | 0.030 |
Why?
|
| Ethylene Glycols | 1 | 2015 | 7 | 0.030 |
Why?
|
| Synaptosomal-Associated Protein 25 | 1 | 2015 | 8 | 0.030 |
Why?
|
| Phenols | 1 | 2015 | 18 | 0.030 |
Why?
|
| Triiodothyronine | 1 | 2014 | 8 | 0.030 |
Why?
|
| Thyrotropin | 1 | 2014 | 7 | 0.030 |
Why?
|
| Thyroxine | 1 | 2014 | 16 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2015 | 188 | 0.030 |
Why?
|
| Thyroid Gland | 1 | 2014 | 16 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 792 | 0.030 |
Why?
|
| Menstruation | 1 | 2014 | 5 | 0.030 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2014 | 30 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 651 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2013 | 44 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2015 | 543 | 0.020 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2013 | 37 | 0.020 |
Why?
|
| Astrocytes | 1 | 2013 | 61 | 0.020 |
Why?
|
| Norepinephrine | 1 | 2013 | 101 | 0.020 |
Why?
|
| Obesity, Abdominal | 1 | 2012 | 24 | 0.020 |
Why?
|
| Lipoproteins, LDL | 1 | 2013 | 99 | 0.020 |
Why?
|
| Cholecalciferol | 1 | 2012 | 25 | 0.020 |
Why?
|
| Food Analysis | 1 | 2012 | 7 | 0.020 |
Why?
|
| Waist Circumference | 1 | 2012 | 91 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 150 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2013 | 143 | 0.020 |
Why?
|
| Vitamins | 1 | 2012 | 71 | 0.020 |
Why?
|
| Cholesterol, Dietary | 1 | 2012 | 40 | 0.020 |
Why?
|
| Range of Motion, Articular | 1 | 2013 | 196 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 1224 | 0.020 |
Why?
|
| Lipoproteins, HDL | 1 | 2013 | 250 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2011 | 276 | 0.020 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2010 | 40 | 0.020 |
Why?
|
| Cervical Intraepithelial Neoplasia | 1 | 2009 | 6 | 0.020 |
Why?
|
| Receptors, Corticotropin-Releasing Hormone | 1 | 2009 | 2 | 0.020 |
Why?
|
| Individuality | 1 | 2009 | 10 | 0.020 |
Why?
|
| Pituitary-Adrenal System | 1 | 2009 | 23 | 0.020 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2009 | 31 | 0.020 |
Why?
|
| DNA, Viral | 1 | 2009 | 55 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 3900 | 0.020 |
Why?
|
| Myositis | 1 | 2009 | 10 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2010 | 292 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 2009 | 45 | 0.020 |
Why?
|
| Pyrroles | 1 | 2009 | 59 | 0.020 |
Why?
|
| Mitochondria | 1 | 2011 | 211 | 0.020 |
Why?
|
| Penile Erection | 1 | 2008 | 31 | 0.020 |
Why?
|
| Pyrimidines | 1 | 2009 | 77 | 0.020 |
Why?
|
| Carbachol | 1 | 2008 | 17 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2012 | 1233 | 0.020 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2008 | 6 | 0.020 |
Why?
|
| Tissue Culture Techniques | 1 | 2008 | 42 | 0.020 |
Why?
|
| Probability | 1 | 2008 | 155 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2012 | 1479 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2008 | 70 | 0.020 |
Why?
|
| 5' Untranslated Regions | 1 | 2007 | 6 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2008 | 239 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2007 | 40 | 0.020 |
Why?
|
| Exons | 1 | 2007 | 52 | 0.020 |
Why?
|
| Absorptiometry, Photon | 1 | 2007 | 98 | 0.020 |
Why?
|
| Collagen Type I | 1 | 2007 | 44 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 556 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 545 | 0.020 |
Why?
|
| Lumbar Vertebrae | 1 | 2007 | 97 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2007 | 203 | 0.020 |
Why?
|
| Peptides | 1 | 2007 | 127 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 897 | 0.020 |
Why?
|
| Child | 1 | 2012 | 2435 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2006 | 64 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2005 | 60 | 0.010 |
Why?
|
| Young Adult | 1 | 2012 | 2649 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2006 | 132 | 0.010 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2004 | 34 | 0.010 |
Why?
|
| Follicular Phase | 1 | 2004 | 10 | 0.010 |
Why?
|
| Luteal Phase | 1 | 2004 | 13 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2005 | 299 | 0.010 |
Why?
|
| Caspases | 1 | 2004 | 41 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2004 | 38 | 0.010 |
Why?
|
| Adolescent | 1 | 2012 | 3519 | 0.010 |
Why?
|
| Ki-67 Antigen | 1 | 2004 | 32 | 0.010 |
Why?
|
| Rats | 1 | 2009 | 1895 | 0.010 |
Why?
|
| Estrogen Antagonists | 1 | 2004 | 16 | 0.010 |
Why?
|
| Biological Availability | 1 | 2004 | 22 | 0.010 |
Why?
|
| Fenfluramine | 1 | 2003 | 5 | 0.010 |
Why?
|
| Serotonin Agents | 1 | 2003 | 6 | 0.010 |
Why?
|
| Prolactin | 1 | 2003 | 9 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2006 | 603 | 0.010 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2002 | 26 | 0.010 |
Why?
|
| Cardiovascular System | 1 | 2002 | 49 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 2002 | 27 | 0.010 |
Why?
|
| Hormone Replacement Therapy | 1 | 2002 | 94 | 0.010 |
Why?
|
| Housing, Animal | 1 | 2002 | 23 | 0.010 |
Why?
|
| Social Isolation | 1 | 2002 | 41 | 0.010 |
Why?
|
| Heart Rate | 1 | 2003 | 362 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2003 | 393 | 0.010 |
Why?
|
| Mice | 1 | 2005 | 2571 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2003 | 417 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2003 | 861 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2003 | 3416 | 0.010 |
Why?
|